| Study |
Reference |
|
Anderson, 2020
|
Anderson Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. JAMA Psychiatry 2020; 77(12):1246-1255. Nembhard Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 2017; 356:j832
|
|
Ankarfeldt (Controls unexposed, NOS), 2023
|
Ankarfeldt Duloxetine Exposure During Pregnancy?and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study. Drugs Real World Outcomes 2023; 10:69-81
|
|
Ankarfeldt (Controls unexposed, sick), 2023
|
Ankarfeldt Duloxetine Exposure During Pregnancy?and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study. Drugs Real World Outcomes 2023; 10:69-81
|
|
Ankarfeldt a (Controls unexposed, NOS), 2021
|
Ankarfeldt Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden. PLoS Med 2021; 18:e1003851
|
|
Ankarfeldt a (Controls unexposed, sick), 2021
|
Ankarfeldt Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden. PLoS Med 2021; 18:e1003851
|
|
Ankarfeldt b (Controls unexposed, sick), 2021
|
Ankarfeldt Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study. Drugs Real World Outcomes 2021; 8:289-299
|
|
Ankarfeldt b Controls unexposed, NOS), 2021
|
Ankarfeldt Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study. Drugs Real World Outcomes 2021; 8:289-299
|
|
Bahat, 2020
|
Bahat, M. Pregnancy outcome after first trimester exposure to Duloxetine Reprod. Toxicol. 2020; 97:3-.
|
|
Huybrechts (Controls unexposed, NOS), 2020
|
Huybrechts Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ 2020; 368:m237
|
|
Huybrechts (Controls unexposed, sick), 2020
|
Huybrechts Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ 2020; 368:m237
|
|
Källen, 2013
|
Källen B The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013;6:1221-86
|
|
Kjaersgaard (Controls unexposed, NOS), 2013
|
Kjaersgaard Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PLoS One 2013; 8:e72095
|
|
Kjaersgaard (Controls unexposed, sick), 2013
|
Kjaersgaard Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PLoS One 2013; 8:e72095
|
|
Marks (Controls exposed to Bupropion), 2021
|
Marks Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy 2021; 41:907-914
|
|
Marks (Controls unexposed, sick), 2021
|
Marks Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy 2021; 41:907-914
|
|
Martin, 2024
|
Martin Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden. medRxiv 2024; :
|
|
Martin - Norway, 2024
|
Martin Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden. medRxiv 2024; :
|
|
Martin - UK, 2024
|
Martin Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden. medRxiv 2024; :
|
|
Ozturk, 2016
|
Ozturk, Z. Safety of psychotropic medications in pregnancy: An observational cohort study Klinik Psikofarmakoloji Bulteni 2016; 26:229-.
|
|
Palmsten, 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
